Rate of viral clearance for interventions relative to the no study arm (This is a superiority comparison);Rate of viral clearance for interventions relative to the positive control arm (This is a non-inferiority or superiority comparison).

Rate of viral clearance for interventions relative to the no study arm (This is a superiority comparison);Rate of viral clearance for interventions relative to the positive control arm (This is a non-inferiority or superiority comparison).

Rate of viral clearance for newly available and repurposed drugs;Rate of viral clearance for positive controls (e.g. monoclonal antibodies);Rate of viral clearance for small novel molecule drugs

Rate of viral clearance for newly available and repurposed drugs;Rate of viral clearance for positive controls (e.g. monoclonal antibodies);Rate of viral clearance for small novel molecule drugs

Rate of viral clearance for repurposed drugs;Rate of viral clearance for small novel molecule drugs;Rate of viral clearance of positive control (monoclonal antibodies) over time relative to the negative control

Rate of viral clearance for repurposed drugs;Rate of viral clearance for small novel molecule drugs;Rate of viral clearance of positive control (monoclonal antibodies) over time relative to the negative control